The FDA’s Office of Prescription Drug Promotion (OPDP) is now offering a new online course as well as educational case studies as part of FDA’s Bad Ad program. This program emphasizes the role of healthcare providers in fighting bad or untruthful drug ads and provides tools to report untruthful or misleading prescription advertisements.  What are your thoughts regarding drug advertisements?

For more information, please see the FDA.